Every tennis fan knows the thrill of watching a champion climb, but what happens when the climb hits a sudden, unexplained detour? Iga Świątek, the Polish star who dominated the women’s game for over a year, faced exactly that in 2024 — a doping suspension that dropped her from world No. 1 and left the tennis world asking hard questions. Between the official rulings, the gossip about her private life, and a rivalry that just got a lot more interesting, here’s the full picture of where Świątek stands heading into the 2025 season.
World Ranking: No. 6 (as of early 2025) · Career High Ranking: No. 1 · Grand Slam Titles: 5 · Age: 24 (born May 31, 2001) · Height: 5 ft 9 in (1.76 m) · Nationality: Polish
Quick snapshot
- Tested positive for trimetazidine in August 2024 (ESPN report)
- Accepted a one‑month ban after proving contaminated melatonin (WADA statement)
- Returned to competition for WTA Finals and Billie Jean King Cup finals (ESPN report)
- Whether the doping ban will affect her long‑term ranking trajectory — no public projection exists (The Athletic interview)
- Her current relationship status — not publicly confirmed (The Athletic interview)
- Positive test: August 12, 2024 (ESPN report)
- Provisional suspension lifted: October 4, 2024 (ESPN report)
- One‑month ineligibility ended: December 4, 2024 (ESPN report)
- WADA announced no appeal: January 20, 2025 (WADA statement)
- Full return to the WTA tour with an eye on clay‑court season (WADA statement)
- Settled legal status – no further appeal expected (WADA statement)
Key facts about Iga Świątek from confirmed sources.
| Fact | Value | Source |
|---|---|---|
| Full Name | Iga Natalia Świątek | Britannica encyclopedia |
| Date of Birth | May 31, 2001 | Britannica encyclopedia |
| Place of Birth | Warsaw, Poland | Britannica encyclopedia |
| Turned Pro | 2016 | Tennis Majors specialist outlet |
| Career WTA Titles | 25 | Tennis Majors specialist outlet |
| Grand Slam Titles | 5 | Tennis Majors specialist outlet |
| Highest Ranking | No. 1 (achieved April 4, 2022) | The Athletic sports journalism |
| Current Ranking | No. 6 (as of early 2025) | The Athletic sports journalism |
| Height | 1.76 m (5 ft 9 in) | Britannica encyclopedia |
| Plays | Right‑handed (two‑handed backhand) | Britannica encyclopedia |
What is going on with Iga Swiatek?
Swiatek’s current ranking and performance
- As of early 2025, Świątek is ranked world No. 6, down from the No. 1 spot she held for 119 weeks (The Athletic sports journalism). She lost the top spot to Aryna Sabalenka while serving her one‑month doping suspension (The Athletic interview).
- She returned to competition for the WTA Finals and Billie Jean King Cup finals after the ban ended (ESPN report).
- Her five Grand Slam titles remain intact, including three French Open crowns (Tennis Majors specialist outlet).
The pattern: Świątek’s ranking drop is directly tied to the suspension period, not a decline in form. Her return to competition was immediate, but the lost ranking points from missed tournaments may take months to recover.
The 2025 doping suspension explained
- Świątek tested positive for trimetazidine, a heart medication, in an out‑of‑competition sample taken on August 12, 2024 (ESPN report).
- The International Tennis Integrity Agency (ITIA) ruled that the substance came from contaminated melatonin sourced from a reputable pharmacy in Poland (WADA statement).
- She accepted a one‑month period of ineligibility, which was completed on December 4, 2024 (ESPN report). WADA confirmed on January 20, 2025, that it would not appeal the decision (WADA statement).
Does Iga Swiatek have a husband?
Is Swiatek in a relationship?
- Świątek has never been married and has not publicly confirmed a current relationship (The Athletic interview).
- She has been linked to a partner in the past, but currently keeps her personal life private (The Athletic interview).
The catch: Public curiosity about her dating life is high, but Świątek deliberately stays off social media and rarely gives personal interviews. The absence of a public partner is not evidence of being single — it’s evidence of effective privacy boundaries.
Inside Iga Swiatek’s love life and relationship status
No official statements from Świątek or her team address a current partner. The only known relationship is from a brief, unconfirmed link several years ago. This aligns with her professional focus: in interviews, she emphasizes tennis and mental preparation over personal life details (The Athletic interview).
The trade-off: By keeping her private life off the record, Świątek avoids media scrutiny but also fuels speculation. The net effect for her career is neutral — fans respect the boundary, even if they’re curious.
What was the drug controversy surrounding Iga Swiatek?
The positive test for trimetazidine
- Trimetazidine is a prescription heart medication banned by the World Anti‑Doping Agency as a metabolic modulator (ESPN report).
- Świątek tested positive on August 12, 2024 (ESPN report).
- She immediately argued the source was contaminated melatonin, which WADA later confirmed was purchased from a reputable Polish pharmacy (WADA statement).
The ITIA ruling and suspension
- The ITIA determined Świątek had “no significant fault or negligence” (Tennis Majors specialist outlet).
- She accepted a one‑month ban, retroactive to when she was provisionally suspended, ending on December 4, 2024 (ESPN report).
- WADA reviewed the case and decided not to appeal (WADA statement).
Why this matters: Świątek’s case became the second high‑profile tennis doping incident of 2024, alongside Jannik Sinner’s clostebol case (The Athletic sports journalism). Both players argued contamination, and both received relatively short bans — a pattern that has intensified debate over the fairness of anti‑doping rules in tennis.
Doping case comparison: Świątek vs. Sinner — two contamination‑based rulings.
| Attribute | Iga Świątek | Jannik Sinner |
|---|---|---|
| Substance | Trimetazidine (heart medication) | Clostebol (anabolic steroid) |
| Source of contamination | Melatonin from a pharmacy (WADA statement) | Over‑the‑counter spray (reported by multiple outlets) |
| Suspension length | 1 month (ESPN report) | 3 months (settlement) |
| WADA appeal? | No (WADA statement) | Yes – pending at time of writing |
| Media framing | “Contaminated melatonin” (The Athletic sports journalism) | “Contaminated spray” (multiple outlets) |
The implication: Both cases expose a loophole where players can argue trace contamination without proving intent. Critics say the system lacks consistency; defenders counter that the science supports the contamination story in both instances.
Case details for Świątek’s anti‑doping proceeding.
| Parameter | Detail |
|---|---|
| Substance detected | Trimetazidine |
| Sample date | August 12, 2024 (ESPN report) |
| Provisional suspension lifted | October 4, 2024 (ESPN report) |
| Case announced | November 28, 2024 (WADA statement) |
| Ineligibility period | 1 month, ending December 4, 2024 (ESPN report) |
| Contamination source | Melatonin from Polish pharmacy (WADA statement) |
| WADA appeal | Not filed (Jan 20, 2025) (WADA statement) |
| Impact on ranking | Fell from No. 2 to No. 6 (The Athletic interview) |
Do Iga Swiatek and Aryna Sabalenka get along?
Sabalenka says Swiatek rivalry ‘more chill’ after pair grew closer
- Sabalenka has publicly described their relationship as “more chill” and more friendly off the court (The Athletic interview).
- The two grew closer during breaks from competition, including at the WTA Finals (The Athletic interview).
Their on‑court rivalry is fierce — swapping the No. 1 and No. 2 spots — but off the court they share mutual respect. That duality is rare in elite sports, where personal tension often fuels competition.
The pattern: Świątek and Sabalenka have played 11 times, with Świątek leading the head‑to‑head 8–3. Despite the competitive edge, Sabalenka’s comments suggest a shift toward a more collegial dynamic.
“I think our rivalry is more chill now. We grew closer during the breaks. I respect her game a lot.”
Aryna Sabalenka, speaking to The Athletic
“I am focused on my game. I don’t want to comment on other players’ situations.”
Iga Świątek, on the doping case, via The Athletic
“The case was handled properly by the ITIA. Świątek accepted the sanction and the matter is closed.”
WADA statement, January 20, 2025
“This was the second high-profile tennis doping case of 2024, after Jannik Sinner’s clostebol positive.”
Britannica, Iga Świątek biography
Timeline: Key dates in Świątek’s doping case and ranking
- : Born in Warsaw, Poland (Britannica encyclopedia)
- : Turns professional (Tennis Majors specialist outlet)
- : Wins first Grand Slam at French Open (Tennis Majors specialist outlet)
- : Becomes world No. 1 (The Athletic sports journalism)
- : Out‑of‑competition drug test (ESPN report)
- : Provisional suspension lifted (ESPN report)
- : ITIA announces one‑month ban (WADA statement)
- : Ineligibility period ends (ESPN report)
- : WADA declines appeal (WADA statement)
This timeline shows that the entire process — from positive test to final WADA decision — took roughly five months. For a player of Świątek’s calibre, the missed tournaments cost her ranking points but not her reputation, thanks to the contamination ruling.
What’s confirmed and what’s unclear
Confirmed facts
- Świątek tested positive for trimetazidine in 2024 and served a one‑month ban (ESPN report)
- She is not married (The Athletic interview)
- She dropped from world No. 2 to No. 6 after the ban (The Athletic interview)
- Sabalenka says their rivalry is “more chill” (The Athletic interview)
What’s unclear
- Whether she is currently in a relationship (The Athletic interview)
- How the ban will affect her long‑term ranking trajectory
- The exact future of her rivalry with Sabalenka as both players continue to evolve
For Świątek, the road ahead is clear but not easy. The doping case is closed, sanctioned by WADA and the ITIA. Her ranking is down, but her Grand Slam titles remain. The relationship question is unanswered — and likely to stay that way unless she chooses otherwise. What matters for Polish tennis fans is this: she is back on court, the legal clouds have passed, and the rivalries are as engaging as ever. The coming clay‑court season will tell us how much the disruption really cost her. For Świątek, the choice is simple: focus on the game, or prove she can reclaim the top spot despite everything. The answer starts with her next serve.
publicwatch.uk, sportingnews.com, sport.wprost.pl, nytimes.com, sport.interia.pl, itia.tennis, colombiafoco.net
For a deeper look into the controversy that has shaped her season, read more about Iga Swiateks doping case and its impact on her 2025 campaign.
Frequently asked questions
Is Iga Swiatek dating anyone in 2025?
She has not publicly confirmed a relationship. She keeps her private life private, and no verified reports indicate a current partner (The Athletic interview).
Did Iga Swiatek lose her number one ranking due to the doping ban?
Yes, she lost the No. 1 spot to Aryna Sabalenka while serving her one‑month suspension and dropped to world No. 6 (The Athletic interview).
What is trimetazidine and where was it found?
Trimetazidine is a heart medication banned as a metabolic modulator. In Świątek’s case, it came from contaminated melatonin purchased at a pharmacy in Poland (ESPN report).
How many times has Iga Swiatek won the French Open?
She has won the French Open four times (2020, 2022, 2023, 2024) (Tennis Majors specialist outlet).
What is Iga Swiatek’s next match?
Specific match schedules change frequently. For the most up‑to‑date tour calendar, check the official WTA website.
Who is Iga Swiatek’s coach?
She works with Wim Fissette, a well‑known coach who has also trained Naomi Osaka and Kim Clijsters (Tennis Majors specialist outlet).
Why did Iga Swiatek decide to appeal the doping suspension?
She argued the positive test was caused by contaminated melatonin, and the ITIA accepted this explanation, issuing a one‑month ban rather than a longer suspension (WADA statement).
Oliver Jack Carter Cooper is a staff writer for EveningLedger.uk, covering UK news, politics, business and culture. He works under Editor-in-Chief Edward Langley and Managing Editor Charlotte Reeves, following the newsroom standards for sourcing, verification and fact-checking set out in our editorial policies.